Status
Conditions
Treatments
About
To evaluate the safety and efficacy of the proposed investigational device and assess its clinical utility in breast cancer screening and diagnosis to support continuing technology development of the investigational technology.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
7,500 participants in 1 patient group
Loading...
Central trial contact
Alexis Cooper; Santina Wendling
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal